Matthew Duvernay

Company: Cartesian Therapeutics

Job title: Senior Director, Quality Control

Seminars:

Building a Strategy for Potency Assay Development 4:00 pm

• Reviewing considerations for lifecycle management of potency assays • Supporting product comparability needs through all stages of product development • Exploring the interplay of manufacturing process development and potency assay development • Understanding considerations for meeting health authority requirements for potency assaysRead more

day: Conference Day One - PM

Panel Discussion: Potency Assay Development Over the Development Lifecycle 4:30 pm

• Should we start potency assay development early? Or should we wait until clearer signals emerge later in subsequent phases  that a therapy is likely to be safe and efficacious?  • How do we translate early phase potency assays into late phase assays?  • At what stage do you begin to qualify and validate? Read more

day: Conference Day One - PM